Hvem er vi

Lundbeckfonden Emerge is led by Christian E. Elling who works closely with the team of Lundbeckfonden Ventures and Lundbeckfonden as well as outside resources complementing the skillset of Lundbeckfonden Emerge.

Lundbeckfonden Emerge

Christian Elling

Managing Partner

Paul Little

Operating Partner

Lundbeckfonden Emerge

Nyheder

Dermtreat Announces First Patient Dosed in Phase 2b Clinical Trial of Rivelin Clobetasol for Oral Lichen Planus
28. juli 2018
Dermtreat sikrer GMP-produktion
4. september 2017
Lundbeckfonden investerer i CRISPR-teknologi til redigering af bakteriers gener
25. august 2017